close

Вход

Log in using OpenID

Legionella Testing Market Analysis, Market Size, Application, Analysis, Regional Outlook, Competitive Strategies and Forecasts, 2014 To 2020

embedDownload
The global legionella testing market is expected to grow at a considerable rate over the forecast period owing to the advancements and automation in the immunodiagnostic market such as the introduction of advanced ELISA antibodies for the prevention
Hexa Research Inc.
Industry Research,Custom Research & Consulting
Legionella Testing Market Analysis, Market Size,
Application, Analysis, Regional Outlook, Competitive
Strategies and Forecasts, 2014 To 2020
The global legionella testing market is expected to grow at a considerable rate over the forecast period
owing to the advancements and automation in the immunodiagnostic market such as the introduction
of advanced ELISA antibodies for the prevention of legionnaires diseases in the market. The rapidly
rising awareness about legionella based diseases and the increase in demand for advanced
immunodiagnostic techniques is a direct consequence of rapidly increasing incidences of mild flu and
pneumonia like diseases through legionella bacteria.
Browse Detail Report With TOC @ http://www.hexaresearch.com/research-report/legionella-testingindustry/
Since legionella bacteria requires the presence of iron and cysteine to grow, it is traditionally detected
by culture on buffered charcoal yeast extract. This process takes 4 to 5 days for detecting the legionella
bacteria. The advanced immunological techniques such as polymerase chain reaction and rapid
immunological assays are efficient to detect the legionella bacteria in few minutes. These techniques are
commonly used to establish the presence of species of Legionella bacteria in the sample.
Hexa Research Inc.
Industry Research,Custom Research & Consulting
Some of the other drivers for the growth of the global legionella testing market include the entry of new
players, new emerging economies such as China and India and increase in the funding for healthcare
facilities by the government in many regions. There are about 40 different species of legionella bacteria
out of which 18 species are infectious. Among all these species, the legionella pneumophilla bacterium
can cause most of the diseases. Many hospitals have started various tests such as legionella urinary
antigen test for the initial detection of legionella based diseases. This is the factor expected to further
fuel the legionella testing market over the forecast period.
Request A Sample copy of This Report @ http://www.hexaresearch.com/sample/132
The legionella testing market has been divided on the basis of antibiotics used for the treatment of
legionella infections into rifampin, azithromycin, ketolides, quinolones and macrolides. It is expected
that Azithromycin drug will grow at the fastest rate throughout the forecast period owing to its
efficiency to treat legionella based diseases. Azithromycin drug is mainly used for treating this infection
in children and adults. The increasing incidences of legionella based diseases in children and adults is
also a factor driving the Azithromycin drug segment in the market.
Apart, certain flouroquinolones such as moxifloxacin and levofloxacin are also considered as the most
efficient drugs for legionella based diseases. There are several diagnostic tests which are available
commercially in the market for initial detection of Legionella bacteria in the body such as sputum or lung
tissue test, urine antigen test, chest X-ray and blood test. There are various end users of legionella
testing drugs which include hospitals, commercial or private labs, physician offices and public health
labs.
Major regions estimated for the legionella testing market are North America, Europe, Asia Pacific and
RoW. As of 2013, North America dominated the market attributing the largest share in terms of
revenue. This large share can be accounted for by the increasing number of patients suffering from
legionella based diseases, the presence of large number of market players and government initiatives
such as various public health labs across the region. Owing to the new emerging economies such as
Germany and U.K. and rising awareness about legionella based diseases in the Europe region, it is
expected that this region will show lucrative growth in the global legionella testing market over the
forecast period.
The key participants in the legionella testing market include Roche Diagnostics, Beckman Coulter, Bio
Rad, Novartis Diagnostics, Life Technology, Becton Dickinson, Abott laboratories, Eiken Chemical, ID
Biomedical, Thermo Fischer, Takara Bio, Kreatech, Gen Probe, Enzo Biochem and SeraCare. The market
leaders in the global legionella testing market are involved in continuous efforts for the development of
Hexa Research Inc.
Industry Research,Custom Research & Consulting
innovative methodologies of testing which would increase the efficiency and accuracy of test results
while providing the smooth processing of larger samples simultaneously. This companies are also
entering into strategic collaborations and expansions to extend their global patient base.
Browse Full Report @ http://www.hexaresearch.com/research-report/legionella-testing-industry/
About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Contact Information:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: [email protected]
Website - http://www.hexaresearch.com/
Visit our Blogs: http://hexaresearch2015.blogspot.com/
1/--pages
Пожаловаться на содержимое документа